Avanos Medical, Inc. (AVNS)

NYSE: AVNS · IEX Real-Time Price · USD
27.99
-0.36 (-1.27%)
Mar 23, 2023, 4:00 PM EDT - Market closed

Company Description

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands.

The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy.

It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.

The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018.

Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical, Inc.
Avanos Medical logo
Country United States
Industry Medical Devices
Sector Healthcare
Employees 4,555
CEO Joseph Woody

Contact Details

Address:
5405 Windward Parkway, Suite 100 South
Alpharetta, Georgia 30004
United States
Phone 844-428-2667
Website avanos.com

Stock Details

Ticker Symbol AVNS
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001606498
CUSIP Number 05350V106
ISIN Number US05350V1061
Employer ID 46-4987888
SIC Code 3842

Key Executives

Name Position
Joseph F. Woody Chief Executive Officer and Director
Michael C. Greiner Senior Vice President, Chief Financial Officer and Principal Accounting Officer
David Edward Ball Senior Vice President of Global Supply Chain and Procurement
William David Haydon Senior Vice President and GM of Pain Management
Kerr W. Holbrook Senior Vice President and GM of Chronic Care
David Crawford Vice President of FP&A and Investor Relations and Treasurer
Michelle Scharfenberg Senior Vice President and Chief Ethics and Compliance Officer
Mojirade James Senior Vice President, General Counsel and Corporate Secretary
Scott Galovan Vice President of Strategy and Corporate Development
Arjun Ranjan Sarker Senior Vice President of International

Latest SEC Filings

Date Type Title
Mar 17, 2023 ARS Filing
Mar 17, 2023 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 17, 2023 DEF 14A Other definitive proxy statements
Mar 6, 2023 8-K Current Report
Feb 21, 2023 10-K Annual Report
Feb 21, 2023 8-K/A [Amend] Current report
Feb 21, 2023 8-K Current Report
Feb 17, 2023 8-K Current Report
Feb 13, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023 SC 13G Statement of acquisition of beneficial ownership by individuals